Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel...

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted...

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Psychedelic Research and Clinical Trials in 2021

Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development...

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

Stephen Hurst Resigns from MindMed Board of Directors

Psychedelic Bulletin: Big Pharma’s Foray Into Psychedelics; Psilocybin Trial Makes Headlines;...

Cybin Announces Additional Adelia Milestone Achievement

PT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest –...

Load more